Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009828 |
---|---|
Receipt number | R000011483 |
Scientific Title | Phase II Study of Bevacizumab in Combination with First-line Platinum-Doublet Chemotherapy in Non-squamous NSCLC Patients with Asymptomatic Untreated Brain Metastases. |
Date of disclosure of the study information | 2013/01/22 |
Last modified on | 2019/01/27 22:34:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/21 13:46:29 | ||
2 | Update | 2013/09/05 18:15:54 | Anticipated trial start date |
|
3 | Update | 2014/01/22 08:48:44 | TEL Address TEL |
|
4 | Update | 2017/07/26 10:31:14 | Name of primary person or sponsor Organization |
|
5 | Update | 2019/01/27 22:34:18 | Recruitment status |